Correlation Between Pmv Pharmaceuticals and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Olema Pharmaceuticals, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Olema Pharmaceuticals.
Diversification Opportunities for Pmv Pharmaceuticals and Olema Pharmaceuticals
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pmv and Olema is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Olema Pharmaceuticals
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.48 times more return on investment than Olema Pharmaceuticals. However, Pmv Pharmaceuticals is 2.1 times less risky than Olema Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 166.00 in Pmv Pharmaceuticals on August 29, 2024 and sell it today you would lose (3.00) from holding Pmv Pharmaceuticals or give up 1.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Olema Pharmaceuticals |
Pmv Pharmaceuticals and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Olema Pharmaceuticals
The main advantage of trading using opposite Pmv Pharmaceuticals and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Pmv Pharmaceuticals vs. Bright Minds Biosciences | Pmv Pharmaceuticals vs. HP Inc | Pmv Pharmaceuticals vs. Intel | Pmv Pharmaceuticals vs. Chevron Corp |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |